Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation.

NCT00423384 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplant

Interventions

DRUG: Placebo
DRUG: Ibandronate

Sponsor

Smerud Medical Research International AS

Collaborators

[object Object]